98,99 €
inkl. MwSt.
Versandkostenfrei*
Erscheint vorauss. 7. Dezember 2025
payback
49 °P sammeln
  • Gebundenes Buch

The search for reliable, sustainable, and environmentally friendly alternatives has become a global trend due to critical limits worldwide regarding increased pharmacological resistance, pharmaceutical pollution and rising human and zoonotic diseases. Although research based on medicinal plants, algae, blood therapy, among others, has not yet reached its peak, it has shown promising results and become a reliable and sustainable hope for combating emerging human diseases.
In recent decades, innovations have included the use of nanovehicles to deliver pharmacologically active compounds,
…mehr

Produktbeschreibung
The search for reliable, sustainable, and environmentally friendly alternatives has become a global trend due to critical limits worldwide regarding increased pharmacological resistance, pharmaceutical pollution and rising human and zoonotic diseases. Although research based on medicinal plants, algae, blood therapy, among others, has not yet reached its peak, it has shown promising results and become a reliable and sustainable hope for combating emerging human diseases.

In recent decades, innovations have included the use of nanovehicles to deliver pharmacologically active compounds, aiming to enhance their curative effect, pharmacological selectivity, and controlled release. While some studies highlight the limitations of nanovehicles/nanodrugs, most acknowledge their superiority over conventional dosing forms. Nanodrugs can overcome various physiological barriers in the human body, providing controlled drug release at the desired site, increasing therapeutic potential, and reducing toxicity. They also enhance pharmacokinetics and pharmacodynamics.

Natural Alternatives and Nanotechnology Applied to the One Health Approach explores the pharmacological potential of various natural sources to combat certain human and zoonotic diseases and the contribution of nanotechnology in dosing active compounds for select diseases.
Autorenporträt
Dr. Michel Heya has a PhD in Sciences with an Orientation in Biotechnology from the Institute of Biotechnology of the Autonomous University of Nuevo Leon, Mexico. He works in the bioprospecting of green alternatives for the treatment of human conditions, as well as in the development of nanomedicines for the pharmacological dosage of various active ingredients. Currently a member of the National System of Researchers and Investigators (SNII), Heya is the author of several scientific articles published in indexed journals and has been a reviewer in journals such as the International Journal of Food Properties and Chemistry & Biodiversity (Web of Sciences Group: ID: 3298-2022). Additionally, Heya is a professor and researcher at the Faculty of Public Health and Nutrition and has participated in the training of scientific resources by directing Master's and Bachelor's theses.